EN 14255-3:2008

Foreword
Introduction
1 Scope
2 Normative references
3 Terms and definitions
   3.1 Symbols, terms and units
   3.2 Definitions
4 Survey of procedures
5 Risk assessment using the solar UV-Index I[UV]
   5.1 General
   5.2 Determination of solar UV-Index I[UV]
   5.3 Risk assessment
   5.4 Decision on protective measures
   5.5 Advantages and limitations
6 Determination and assessment of the skin exposure
   factor
   6.1 General
   6.2 Skin exposure factor
        6.2.1 General
        6.2.2 Calculation of the skin exposure factor
        6.2.3 Assessment
   6.3 Advantages and limitations
7 Calculation of solar radiation exposures by
   radiative transfer models
   7.1 General
   7.2 Models for the calculation of UV-exposure
   7.3 Assessment of the result
   7.4 Necessity of protective measures
   7.5 Advantages and limitations of the procedures
8 Measurement of erythemal effective radiant exposure H[er]
   8.1 General
   8.2 Quantities to be measured
   8.3 Description of the methods
   8.4 Advantages and limitations
9 Measurement of non-melanoma skin cancer radiant
   exposure H[nmsc]
   9.1 General
   9.2 Procedure
   9.3 Protective measures
   9.4 Advantages and limitations
10 Measurement and assessment according to EN 14255-1
   10.1 General
   10.2 Procedure
   10.3 Protective measures
   10.4 Advantages and limitations
11 Sun protection measures
Annex A (normative) - Relation between skin type
                      and minimal erythema dose
Annex B (informative) - Examples of protective measures
Annex C (informative) - UV skin and eye risks
Annex D (informative) - Methods for the measurement of
                        solar erythemal effective radiant
                        exposure H[er]
   D.1 General
   D.2 Methods A to F for the measurement of the erythemal
       effective radiant exposure H[er]
       D.2.1 General
       D.2.2 Method A
       D.2.3 Method B
       D.2.4 Method C
       D.2.5 Method D
       D.2.6 Method E
       D.2.7 Method F
Bibliography